Italy asked to fully implement EU medicines law to support generic drug competition
This article was originally published in SRA
Executive Summary
The European Commission has given Italy two months to fully implement the provisions of the EU medicines legislation on marketing authorisation procedures for generic drugs1. Implementation of the provisions would override an Italian law that currently puts generics manufacturers at a disadvantage on the market.